News

Genetic Analysis partners up to enter the consumer market with GA-map®

OSLO, NORWAY – December 21, 2023: Today, Microbiome DX company Genetic Analysis AS (“GA” or the “Company”) announces a collaboration…

OSLO, NORWAY – December 13, 2023: Today, the Microbiome DX company Genetic Analysis AS (“GA” or the “Company”) publishes a…

Tradable subscription rights available until 22.12.2023 at 12: 00 CET Genetic Analysis AS has issued subscription rights (ticker: GEAN TR…

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, JAPAN, CANADA, NEW…

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, JAPAN, CANADA, NEW…

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, JAPAN, CANADA, NEW…

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, THE UNITED KINGDOM, AUSTRALIA, JAPAN, CANADA, NEW…

Outcome TO2 options warrants

OSLO, NORWAY – 20 November 2023: Genetic Analysis AS (“GA” or “the Company”) announces that members of the Board and…

Oslo, Norway, November 20, 2023 – Genetic Analysis AS (the “Company”, Ticker: GEAN) held an Extraordinary General Meeting today, November…

Genetic Analysis recently participated in xMAP® Connect EMEA, an industry conference November 8-9 in Amsterdam organized by Luminex Corporation –…

Commercial director, Mr. Detlef Janke, is attending the Medica Trade Fair in Düsseldorf, Germany. He would be more than happy…

Notice is hereby served that an extraordinary general meeting in Genetic Analysis AS (the “Company”) will be held on Monday…

OSLO, NORGE – 3 november, 2023 – Den 8 november 2023 inleds nyttjandeperioden för de teckningsoptioner av serie TO 2…

Correction of press release regarding subsequent offer